help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonino, N.
Right arrow Articles by Boscaro, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonino, N.
Right arrow Articles by Boscaro, M.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 2647-2652, Copyright © 1996 by Endocrine Society


ARTICLES

Risk factors and long-term outcome in pituitary-dependent Cushing's disease

N Sonino, M Zielezny, GA Fava, F Fallo and M Boscaro
Division of Endocrinology, University of Padova, Italy.

Although transphenoidal pituitary microsurgery has become the treatment of choice in Cushing's disease, other procedures, such as bilateral adrenalectomy and pituitary irradiation, are currently in use in its management. Indeed, no treatment has proven to be fully satisfactory for this condition. The rates of cure and recurrence after pituitary surgery or irradiation and the incidence of Nelson's syndrome after bilateral adrenalectomy are still open issues. A population of 162 patients with pituitary-dependent Cushing's disease was studied at 1 institution and had a follow-up of at least 2 yr after treatment (median, 7 yr). Patients were divided in subgroups according to the type of treatment: transsphenoidal pituitary microsurgery, bilateral adrenalectomy, or pituitary irradiation. Survival analysis was employed to characterize the outcome of treatment in each subgroup. Predictive factors for success of pituitary surgery were also evaluated. The estimated cumulative percentage of patients remaining in remission after successful pituitary surgery (n = 79) was 93.7% after 2 yr, 80.6% after 5 yr, 78.5% after 7 yr, and 74.1% after 10 yr. Of 8 risk factors examined, the following attained statistical significance: age, clinical severity, presence of major depression, pre- and posttreatment urinary cortisol levels, and posttreatment ACTH level. Pituitary surgery was successful in 79 of 103 patients (76.7%). Surgical failure was significantly associated with lack of pituitary adenoma and the clinical severity and presence of major depression. Of patients treated by bilateral adrenalectomy (n = 63), the estimated cumulative percentage remaining free of Nelson's syndrome was 87.1% after 2 yr, 79.3% after 7 yr, and 71.2% after 10 yr. The occurrence of Nelson's syndrome was significantly related to the pretreatment urinary cortisol level and the presence of pituitary adenoma at previous pituitary surgery. After cure by pituitary irradiation (n = 23), the estimated cumulative percentage of patients remaining in remission was 100% after 2 yr, 81.8% after 5 yr, 71.6% after 7 yr, and 65.1% after 10 yr. Previous pituitary surgery, although unsuccessful, appeared to be a protective factor for relapse. The results indicate that relapse after cure by either pituitary surgery or irradiation is a considerable clinical problem that increases over time. Our findings ascribe new importance to the clinical presentation of patients and indicate subgroups that are at high risk for relapse after pituitary surgery or irradiation and for developing Nelson's syndrome after bilateral adrenalectomy.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Jehle, J. E. Walsh, P. U. Freda, and K. D. Post
Selective Use of Bilateral Inferior Petrosal Sinus Sampling in Patients with Adrenocorticotropin-Dependent Cushing's Syndrome Prior to Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4624 - 4632.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. K. Biller, A. B. Grossman, P. M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A. R. Hermus, L. J. Hofland, et al.
Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2454 - 2462.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. G. Patil, D. M. Prevedello, S. P. Lad, M. L. Vance, M. O. Thorner, L. Katznelson, and E. R. Laws Jr.
Late Recurrences of Cushing's Disease after Initial Successful Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 358 - 362.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F Castinetti, I Morange, P Jaquet, B Conte-Devolx, and T Brue
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
Eur. J. Endocrinol., January 1, 2008; 158(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Pouratian, D. M. Prevedello, J. Jagannathan, M. B. Lopes, M. L. Vance, and E. R. Laws Jr.
Outcomes and Management of Patients with Cushing's Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3383 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. van der Hoek, S. W J Lamberts, and L. J Hofland
Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S45 - S51.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Assie, H. Bahurel, J. Coste, S. Silvera, M. Kujas, M.-A. Dugue, F. Karray, B. Dousset, J. Bertherat, P. Legmann, et al.
Corticotroph Tumor Progression after Adrenalectomy in Cushing's Disease: A Reappraisal of Nelson's Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 172 - 179.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R T Netea-Maier, E J van Lindert, M den Heijer, A van der Eerden, G F F M Pieters, C G J Sweep, J A Grotenhuis, and A R M M Hermus
Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.
Eur. J. Endocrinol., May 1, 2006; 154(5): 675 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. S. Woo, A. M. Isidori, W. Z. Wat, G. A. Kaltsas, F. Afshar, I. Sabin, P. J. Jenkins, J. P. Monson, G. M. Besser, and A. B. Grossman
Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4963 - 4969.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. L Storr, F. Afshar, M. Matson, I. Sabin, K. M Davies, J. Evanson, P N. Plowman, G M. Besser, J. P Monson, A. B Grossman, et al.
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease
Eur. J. Endocrinol., June 1, 2005; 152(6): 825 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. D. Hammer, J. B. Tyrrell, K. R. Lamborn, C. B. Applebury, E. T. Hannegan, S. Bell, R. Rahl, A. Lu, and C. B. Wilson
Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Long-Term Results
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6348 - 6357.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. A. F. S. Rollin, N. P. Ferreira, M. Junges, J. L. Gross, and M. A. Czepielewski
Dynamics of Serum Cortisol Levels after Transsphenoidal Surgery in a Cohort of Patients with Cushing's Disease
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1131 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al.
Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Pereira, M. O. van Aken, H. van Dulken, P. J. Schutte, N. R. Biermasz, J. W. A. Smit, F. Roelfsema, and J. A. Romijn
Long-Term Predictive Value of Postsurgical Cortisol Concentrations for Cure and Risk of Recurrence in Cushing's Disease
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5858 - 5864.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Boscaro, N. Sonino, A. Scarda, L. Barzon, F. Fallo, M. T. Sartori, G. M. Patrassi, and A. Girolami
Anticoagulant Prophylaxis Markedly Reduces Thromboembolic Complications in Cushing's Syndrome
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3662 - 3666.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lindholm, S. Juul, J. O. L. Jørgensen, J. Astrup, P. Bjerre, U. Feldt-Rasmussen, C. Hagen, J. Jørgensen, M. Kosteljanetz, L. O. Kristensen, et al.
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 117 - 123.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
R.R. Gonzalez, A. Palomino, A. Boric, M. Vega, and L. Devoto
A quantitative evaluation of {alpha}1, {alpha}4, {alpha}V and {beta}3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal
Hum. Reprod., October 1, 1999; 14(10): 2485 - 2492.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Newell-Price, P. Trainer, M. Besser, and A. Grossman
The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States
Endocr. Rev., October 1, 1998; 19(5): 647 - 672.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Devoe, W. L. Miller, F. A. Conte, S. L. Kaplan, M. M. Grumbach, S. M. Rosenthal, C. B. Wilson, and S. E. Gitelman
Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3196 - 3202.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos
The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Utiger
Treatment, and Retreatment, of Cushing's Disease
N. Engl. J. Med., January 16, 1997; 336(3): 215 - 217.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society